UNSPSC 51402004: Procymate

This classification denotes a sedative and hypnotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 308EUN932K. European Medicines Agency schedules Procymate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10065MIG. Procymate generally arises in the molecular formula C10H19NO2. The term PROCYMATE is an International Non-Proprietary Name or INN. PROCYMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule procymate under HS 29242995 and SITC 51479. As of Q4 2014, PROCYMATE remains the US FDA Preferred Term for this commodity. Procymate bears US NLM identifiers UMLS ID C1882469 and NCI Concept Code C66473. SMILES: CCC(C1CCCCC1)OC(=O)N.

UNSPSC 51402004 Procymate is a Commodity code under which state and local governments procure naloxone, drug deactivation systems, generic pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing vehicles. The work encompasses both emergency medical countermeasure procurement (naloxone kits and safe drug deactivation systems for public health and harm-reduction initiatives) and broader pharmaceutical supply chain management for multi-jurisdictional health benefit programs. Issuing bodies include county health departments, state health and human services agencies, and multi-state cooperative purchasing alliances serving state and local government members across multiple jurisdictions and facility types.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs for self-insured employee group health plans and state agencies outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with March 26, 2026 response deadline, targeting July 1, 2026 contract start and distribution through authorized wholesalers AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC to participating state and local government facilities including Oregon.